Crossmark

Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

Crossref DOI link: https://doi.org/10.1186/S13024-017-0154-3

Published Online: 2017-01-25

Published Print: 2017-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Moors, Tim E. http://orcid.org/0000-0003-2223-9947
Hoozemans, Jeroen J. M.

Ingrassia, Angela

Beccari, Tommaso

Parnetti, Lucilla

Chartier-Harlin, Marie-Christine

van de Berg, Wilma D. J.
Funding

Funding for this research was provided by:

Association France Parkinson (2015, R16008EE)

ZonMw Memorabel

Roche Innovation Center

Internationale Stichting Alzheimer Onderzoek (ISAO)

Ligue Europeénne contre la Maladie d'Alzheimer

LECMA (RD1507)

University of Lille-CNRS and Region Hauts de France (PEPS 2016)

Ministère des affaires sociales et de la santé/CHR (PHRC park de novo, and Bonus H, 2014)

Michael J. Fox Foundation for Parkinson's Research (ID 10609, ID 5244, ID 011215)